TY  - JOUR

T1  - Abstract B109: MTHFD1/2 inhibitor TH9619 targets the DNA damage response and causes cancer-specific folate trapping with an unprecedented therapeutic window

JO  - Molecular Cancer Therapeutics

UR  - http://dx.doi.org/10.1158/1535-7163.targ-23-b109

PY  - 2023/12/01

AU  - Martilla P

AU  - Green AC

AU  - Kiweler N

AU  - Chalkiadaki C

AU  - Wiita E

AU  - Cookson V

AU  - Lesur A

AU  - Eiden K

AU  - Bernhardin F

AU  - Long M

AU  - Jemth A-S et al

ED  - 

DO  - DOI: 10.1158/1535-7163.targ-23-b109

PB  - American Association for Cancer Research (AACR)

VL  - 22

IS  - 12_Supplement

SP  - B109

EP  - B109

Y2  - 2024/09/19

ER  -